Rx · PZN 19403491

VAXIGRIP 2025-2026 suspension for injection pre-filled syringe with needle

German trade nameVAXIGRIP 2025-2026 Injektionssuspension Fertigspritze mit Kanüle

Active ingredientInfluenza, inactivated, split virus or surface antigenSubstance (DE)Influenza, inaktiviert, Spaltvirus oder OberflächenantigenPharmaceutical formSuspension for injection

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €102

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for VAXIGRIP 2025-2026 suspension for injection pre-filled syringe with needle.

Review purchasing terms

VAXIGRIP 2025-2026 suspension for injection pre-filled syringe with needle contains the active ingredient Influenza, inactivated, split virus or surface antigen (German Influenza, inaktiviert, Spaltvirus oder Oberflächenantigen) and comes as Suspension for injection. One pack size is recorded (PZN 19403491). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.

VAXIGRIP 2025-2026 suspension for injection pre-filled syringe with needle was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.